Cordis announced the FDA has approved its self-expanding vascular stent designed for transradial peripheral procedures in the iliac and superficial femoral arteries.
The self-expanding stent (S.M.A.R.T. Radianz) is part of the company’s peripheral system that includes a guiding sheath (Brite Tip Radianz) and percutaneous transluminal angioplasty catheter (Saberx Radianz), according to a press release from the company.
According to the release, 1-year revascularization rates were similar between the self-expanding stent and a drug-coated stent, and the self-expanding stent was associated